Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

Q: What does CUSIP 877619106 represent in this 13F holders report?

CUSIP 877619106 is the security identifier for TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share in Q2 2021?

48 institutional investors reported TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 877619106

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, par value $0.00001 per share
Shares outstanding: 275,000,000
Total 13F shares: 18,320,557
Share change: +659,515
Total reported value: $388,394,891
Price per share: $21.20
Number of holders: 48
Value change: +$15,022,269
Number of buys: 36
Number of sells: 13

Quarterly Holders Quick Answers

What is CUSIP 877619106?
CUSIP 877619106 identifies TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 877619106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	2.1%	5,664,215	$114,984,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	0.82%	2,261,245	$45,905,000	—	31 Mar 2021	13F
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	13F	Company	0.79%	2,179,000	$44,234,000	—	31 Mar 2021	13F
FRANKLIN RESOURCES INC	13F	Company	0.41%	1,119,169	$22,719,000	—	31 Mar 2021	13F
Artal Group S.A.	13F	Company	0.38%	1,040,882	$21,130,000	—	31 Mar 2021	13F
Casdin Capital, LLC	13F	Company	0.3%	820,440	$16,655,000	—	31 Mar 2021	13F
SANDS CAPITAL MANAGEMENT, LLC	13F	Company	0.26%	724,873	$14,715,000	—	31 Mar 2021	13F
Alphabet Inc.	13F	Company	0.23%	640,882	$13,010,000	—	31 Mar 2021	13F
TYBOURNE CAPITAL MANAGEMENT (HK) LTD	13F	Company	0.18%	500,000	$10,150,000	—	31 Mar 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.17%	470,440	$9,548,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	0.17%	460,248	$9,343,000	—	31 Mar 2021	13F
TimesSquare Capital Management, LLC	13F	Company	0.14%	397,200	$8,063,000	—	31 Mar 2021	13F
Octagon Capital Advisors LP	13F	Company	0.12%	320,440	$6,505,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.06%	152,462	$3,094,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	0.04%	122,141	$2,479,000	—	31 Mar 2021	13F
VR Adviser, LLC	13F	Company	0.04%	120,649	$2,449,000	—	31 Mar 2021	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.04%	115,723	$2,349,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.04%	96,924	$1,968,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	58,243	$1,183,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	57,412	$1,166,000	—	31 Mar 2021	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.01%	37,824	$768,000	—	31 Mar 2021	13F
Nantahala Capital Management, LLC	13F	Company	0.01%	36,956	$750,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	0.01%	36,211	$735,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.01%	26,932	$546,000	—	31 Mar 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	26,223	$532,000	—	31 Mar 2021	13F
Alyeska Investment Group, L.P.	13F	Company	0.01%	25,000	$508,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.01%	22,961	$466,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.01%	21,125	$429,000	—	31 Mar 2021	13F
DAVENPORT & Co LLC	13F	Company	0.01%	20,150	$409,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.01%	17,601	$357,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	14,855	$301,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0%	13,128	$266,000	—	31 Mar 2021	13F
HRT FINANCIAL LP	13F	Company	0%	12,239	$248,000	—	31 Mar 2021	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0%	8,800	$179,000	—	31 Mar 2021	13F
DEUTSCHE BANK AG\	13F	Company	0%	5,852	$119,000	—	31 Mar 2021	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	5,059	$103,000	—	31 Mar 2021	13F
STRS OHIO	13F	Company	0%	2,100	$42,000	—	31 Mar 2021	13F
CAPTRUST FINANCIAL ADVISORS	13F	Company	0%	961	$20,000	—	31 Mar 2021	13F
Legal & General Group Plc	13F	Company	0%	914	$18,000	—	31 Mar 2021	13F
ROYAL BANK OF CANADA	13F	Company	0%	875	$18,000	—	31 Mar 2021	13F
Ameritas Investment Partners, Inc.	13F	Company	0%	727	$15,000	—	31 Mar 2021	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	626	$13,000	—	31 Mar 2021	13F
CITIGROUP INC	13F	Company	0%	576	$12,000	—	31 Mar 2021	13F
RBC Europe Ltd	13F	Company	0%	250	$5,075	—	31 Mar 2021	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	268	$5,000	—	31 Mar 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	241	$5,000	—	31 Mar 2021	13F

Institutional Holders of Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) as of Q2 2021

As of 30 Jun 2021, Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,320,557 shares. The largest 10 holders included FMR LLC, BlackRock Inc., UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO, FRANKLIN RESOURCES INC, Artal Group S.A., SANDS CAPITAL MANAGEMENT, LLC, TimesSquare Capital Management, LLC, Alphabet Inc., VANGUARD GROUP INC, and TYBOURNE CAPITAL MANAGEMENT (HK) LTD. This page lists 48 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.